HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Markwins Restages Black Radiance, Tropez Ethnic Brands To Boost Sales

This article was originally published in The Rose Sheet

Executive Summary

Markwins is seeking to drive its ethnic business by updating the Black Radiance and Tropez lines with new packaging and promotional activities, Senior VP and Beauty Products General Manager Jim Koeppl said

You may also be interested in...



Markwins Launches Bratz Cosmetics, Victoria Jackson Beauty

Bratz cosmetics is expected to evolve into a $10 mil. -$12 mil. brand in the U.S. within three to four years of its launch, according to Markwins International. The beauty company recently announced an agreement with entertainment products company MGA Entertainment to license the Bratz doll brand name for color cosmetics

Markwins Launches Bratz Cosmetics, Victoria Jackson Beauty

Bratz cosmetics is expected to evolve into a $10 mil. -$12 mil. brand in the U.S. within three to four years of its launch, according to Markwins International. The beauty company recently announced an agreement with entertainment products company MGA Entertainment to license the Bratz doll brand name for color cosmetics

Markwins Wet ‘n’ Wild Ad Campaign Aims To Increase Market Share By 2006

Markwins International will triple its ad spend for Wet 'n' Wild next year, the firm said Dec. 2. The company launched the cosmetics brand's inaugural advertising campaign this August

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel